Detall de l'activitat



Novembre
19
2020
XIVth Congress Catalan Society of Immunology (SCI). Joint meeting with European Federation of Immunological Societies on Tour (EFIS on TOUR)
Congrés
Societat Catalana d'Immunologia
Dies 19 i 20 de novembre de 2020 | Online
19-11-2020 | 15:30 - 20:15 | Online
15:30 - 16:00Arrival, Registration and Documentation delivery ( Lliurament de la documentació )
16:00 - 16:15Welcome to the XIVth CONGRESS of the SCI ( Sessió )
Presentador/a: Dr. Marcos López Hoyos. President of the SEI
Presentador/a: Dr. Ricardo Pujol Borrell. President of the SCI
16:15 - 17:00Opening Lecture – ( Sessió )
Immunological memory against the dogma
Moderador/a: Dr. Pablo Engel Rocamora. University of Barcelona
Ponent: Dr. Andreas Radbruch. Charité, Universitätsmedizin Berlin
17:00 - 17:30Poster viewing ( Sessió )
17:30 - 18:00Plenary Session: Inter-TCR crosstalk during antigen recognition. ( Sessió )
Moderador/a: Dra. Annabel Valledor. University of Barcelona
Ponent: Dr. Balbino Alarcón. Centro Biología Molecular Severo Ochoa, Madrid
18:00 - 19:45Oral Communications, Session-1 – Basic and Experimental Immunology ( Sessió )
Moderador/a: Dr. Winfried Pickl. Medical University of Vienna
Experimental and genetic evidence for the involvement of CD6 in inflammatory bowel diseases.
Ponent: Dr. Sergi Casadó Llombar. et al.
Macrophage mitochondrial MFN2 (mitofusin 2) links immune stress and immune response through reactive oxygen species (ROS) production
Ponent: Dr. Antonio Celada. et al.
Immunomodulation of type 1 diabetes by 116C-NOD intestinal microbiota
Ponent: Dra. Estela Rosell Mases. et al.
siRNA-containing transfection of vitamin D3-induced tolerogenic dendriticcells for the silencing of potential tolerogenic genes
Ponent: Dr. Íñigo González Larreategui. et al.
Immunomodulatory properties of a soluble cytomegalovirus-encoded CD48 Homolog.
Ponent: Dr. Francesc Poblador. et al.
MRL mice infected with cytomegalovirus (CMV) as an animal model of Sjögren’s Syndrome.
Ponent: Dr. Joan Puñet Ortiz. et al.
HIV-1 enveloped Virus-Like Particles (VLP) displaying high density of HIV-1 Env-derived antigens on their surface induce a functional immune response beyond neutralizing activity
Ponent: Dr. Ferran Tarrés Freixas. et al.
19:25 - 19:45Discussion (Oral Communications, Session-1 – Basic and Experimental Immunology) ( Sessió )
19:45 - 20:15Plenary Session: The role of a new T helper cell type, Th-IL-2 cells, in allergic immune reactions ( Sessió )
Moderador/a: Dra. Eva Maria Martinez Carceres. Autonomus University of Barcelona
Ponent: Dr. Winfried Pickl. Medical University of Vienna
20-11-2020 | 08:30 - 20:00 | Online
08:30 - 09:00Arrival, Registration and Documentation delivery ( Sessió )
09:00 - 09:30Plenary Session: Tissue memory cells at the center of the immune system ( Sessió )
Moderador/a: Dra. Dolores Jaraquemada Perez de Guzmán. Autonomous University of Barcelona
Ponent: Dr. René Van Lier. Sanquin Blood Supply. University of Amsterdam
09:30 - 10:00Plenary Session: Development of humen “adaptive” NK cell populations: open issues. ( Sessió )
Moderador/a: Dr. Miguel López Botet. University Pompeu Fabra, Barcelona
Moderador/a: Dr. Pablo Engel Rocamora. University of Barcelona
10:00 - 11:30Oral Communications, Session 2: Clinical Immunology I ( Sessió comunicacions )
Moderador/a: Dra. Cristina Costa Vallès. (IDIBELL, Barcelona
Moderador/a: Dra. Mª Rosa Faner Canet. Hospital Clinic, Barcelona
Changes induced in lymphocyte subpopulations by dimethyl-fumarate treatment in multiple sclerosis could identify “NEDA” patients.
Ponent: Dra. Aina Teniente Serra. et al.
Lymphocyte subpopulations analysis in psoriatic patients treated with biological drugs
Ponent: Dr. Marc Boigues Pons. et al.
Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the effect of Maintenance Immunotherapy
Ponent: Dra. María Iglesias Escudero. et al.
Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients
Ponent: Dra. Michelle Ataya. et al.
Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients
Ponent: Dra. Tamara Cruz. et al.
Immunophenotype in CU patients under omalizumab treatment.
Ponent: Dra. Cristina Alejandra López Rodriguez
11:30 - 12:00Plenary Session: Conventional and unconventional T cell response to microbial antigens. ( Sessió )
Moderador/a: Dr. Ricardo Pujol Borrell. Autonomous University of Barcelona
Ponent: Dra. Federica Sallusto. Institute for Research in Biomedicine Bellinzona
12:00 - 13:00Ordinary General Meeting- Societat Catalana d’Immunologia ( Sessió )
13:00 - 13:30Poster viewing ( Sessió comunicacions )
13:30 - 14:00Lunch session sponsored by Becton Dickinson.Resolving immune cell identity one cell at time. The multiomic approach. ( Càtering )
Ponent: Dr. Werner Rodriguez. BD Biosciences | Single Cell Multiomics
14:30 - 16:15Oral Communications, Session 3: Tumor Immunology and Immunotherapy ( Sessió comunicacions )
Moderador/a: Dr. Manel Juan Otero. Hospital Clinic. Barcelona
Phase I multicenter clinical trial with chimeric antigen receptor with humanized anti-BCMA specific ( ARI0002h) in patients with relapsed or refractory multiple myeloma
Ponent: Dra. Mariona Pascal Capdevila. et al.
CART19-BE-01: un ensayo académico Europeo sobre la administración de células CAR-T denominadas ARI-0001 en pacientes con trastornos linfoproliferativos CD19+.
Ponent: Dr. Valentín Ortiz Maldonado. et al.
Humoral immune response in patients with CD19 positive relapsed/refractory B-cell malignances recruited into the CART19-BE-01 clinical trial
Ponent: Dra. Ariadna Bartoló Ibars. et al.
Comparative analysis and characterization of TCR repertoires in breast cancer TILs
Ponent: Dra. Andrea Aran Garriga. et al.
HAVCR2 mutations altering TIM-3 underlying hemophagocytic syndrome and subcutaneous panniculitis-like T-cell lymphoma.
Ponent: Dr. Roger Colobran Oriol. et al.
Dynamics of T-cell subsets in non-small cell lung cancer patients treated with PD-1/PD-L1 axis blocking mAbs
Ponent: Dra. Coral Zurera Egea. et al.
NK cell receptors and ligand variants modulate response to tyrosine kinaseinhibitors in patients with chronic myeloid leukemia
Ponent: Dra. Laia Closa Gil. et al.
15:55 - 16:15Discussion (Oral Communications, Session 3: Tumor Immunology and Immunotherapy) ( Sessió )
16:15 - 16:45Plenary Session: Unconventional receptor-based antibodies ( Sessió )
Moderador/a: Dr. Miguel López Botet. (University Pompeu Fabra , Barcelona
Ponent: Dr. Antonio Lanzavecchia. National Institute of Molecular Genetics, Milan
16:45 - 18:00Oral Communications, Session 4: COVID-19 ( Sessió comunicacions )
Moderador/a: Dra. Silvia Vidal Alcorisa. Santa Creu i Sant Pau Hospital, Barcelona
Early S2-targeting and rapid development of neutralizing antibodies after SARS-CoV-2 infection.
Moderador/a: Dra. Maria Luisa Rodriguez de la Concepción. et al.
Antigen-specific lymphocyte proliferation against SARS-CoV-2 in COVID patients with negative antibodies against the virus in serum
Ponent: Dra. Marc Boigues Pons. et al.
Immunological Risk Profile in COVID-19, the Experience of a Single Academic Hospital in Catalonia.
Ponent: Dr. Manuel Hernández González . et al.
Immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome: overlap with Kawasaki disease and identification of a distinct severe group
Ponent: Dra. Ana Esteve Solé. et al.
Revealing protective T cell immune responses against SARS-CoV-2.
Ponent: Dra. Judith Grau Expósito. et al.
Inborn errors and autoantibodies against type-I inteferons in patients with life-threatening COVID-19.
Ponent: Dr. Roger Colobran Oriol. et al.
17:45 - 18:00Discussion.(Oral Communications, Session 4: COVID-19) ( Sessió )
18:00 - 18:15Prize to the best communication and poster ( Sessió )
Ponent: Dr. Ricardo Pujol Borrell. (President of SCI
18:15 - 18:30Closing of the Congress ( Sessió cloenda )
Presentador/a: Dr. Ricardo Pujol Borrell. (President of SCI